Garlic-derived compound S-allylmercaptocysteine inhibits cell growth and induces apoptosis via the JNK and p38 pathways in human colorectal carcinoma cells

Yan Zhang, H. Li, Zhihua Zhang, Honglei Bian, Lin GuiOncology 2014 · DOI

Abstract

S-allylmercaptocysteine (SAMC), an active compound derived from garlic, has demonstrated significant antitumor properties in vitro. This study investigated the effects of SAMC on human colorectal carcinoma (SW620) cells and the underlying molecular mechanisms. Results showed that SAMC reduces cell viability in a dose- and time-dependent manner by inducing apoptosis through the JNK and p38 signaling pathways, leading to increased p53 and Bax activation. The optimal concentration for inducing apoptosis was identified as 400 μM. These findings suggest SAMC's potential as a novel therapeutic agent for colorectal carcinoma.

Introduction: Addressing Colorectal Carcinoma

Colorectal cancer is a major global health concern, necessitating the discovery of new preventive and therapeutic strategies. While garlic consumption is epidemiologically linked to lower cancer risk, the precise molecular mechanisms of its active compounds, such as SAMC, remain under-explored. This research aims to elucidate how SAMC, a water-soluble organosulfur compound from aged garlic extract, interacts with cellular signaling to inhibit cancer cell proliferation.

Methodology

The researchers utilized the SW620 human colorectal carcinoma cell line to evaluate SAMC's efficacy through several key techniques:

  • MTT Assay: Measured metabolic activity to determine cell survival across concentrations (0–450 µM) and time points (12–72 h).
  • TUNEL Assay: Employed fluorescent staining to visualize DNA fragmentation, a definitive marker of apoptosis.
  • Gene Expression Analysis: Used RT-PCR and qPCR to quantify mRNA levels of JNK and p38 pathway components (including RAC1, DAXX, ASK1, and MKK3) and apoptotic markers (p53, Bax, Bcl-2).

Key Results and Insights

Dose- and Time-Dependent Growth Inhibition

SAMC treatment resulted in a significant reduction in SW620 cell viability. This effect was both dose-dependent and time-dependent, with the most pronounced inhibition observed at higher concentrations over longer exposure periods.

Figure 3: SAMC reduces SW620 cell viability in a dose- and time-dependent manner.

Induction of Apoptosis

The reduction in cell viability was primarily attributed to the induction of programmed cell death. TUNEL staining confirmed a substantial increase in apoptotic cells at the 400 µM concentration compared to untreated controls.

Figure 2: TUNEL assay results showing significant DNA fragmentation (green) in cells treated with 400 μM SAMC, indicating apoptosis.

Molecular Signaling Pathways

The study mapped a clear signaling cascade:

  1. Upstream Activation: SAMC stimulates regulators like RAC1 and DAXX.
  2. MAPK Pathways: These regulators activate the JNK and p38 mitogen-activated protein kinase pathways.
  3. p53 Convergence: Stress signaling converges on the tumor suppressor p53.
  4. Apoptotic Execution: Activation of p53 increases the pro-apoptotic protein Bax and decreases the anti-apoptotic protein Bcl-2, triggering cell death.

Discussion and Future Directions

While these in vitro results are promising, several hurdles remain before clinical application. The study's reliance on cell cultures means that in vivo validation is essential to understand SAMC's metabolism and delivery within a complex tumor microenvironment. Furthermore, the dietary feasibility of achieving a 400 µM concentration in human tissue requires investigation. Future work should also explore additional signaling mechanisms that might contribute to SAMC's anticancer effects.

Summary updated

Abstract

S-allylmercaptocysteine (SAMC) is an active compound that is derived from garlic and has been demonstrated to possess antitumor properties <i>in vitro</i>. The present study aimed to investigate the effect of SAMC and determine the underlying mechanism of this effect on human colorectal carcinoma cells. The SW620 cells were cultured with various concentrations of SAMC and cell viability was detected using an MTT assay. Analysis of apoptosis was performed using terminal deoxynucleotidyl-transferase-mediated deoxyuridine triphosphate nick end labeling. The c-Jun N-terminal kinase (JNK) and p38 mitogen activated protein kinase (p38) signaling pathways were investigated by polymerase chain reaction. SAMC was observed to reduce cell viability in a dose- and time-dependent manner, partially through the induction of apoptosis in human colorectal carcinoma cells. At the molecular level, SAMC induces apoptosis through JNK and p38 signaling pathways, increasing tumor protein p53 (p53) and Bax activation in the SW620 cells. The most effective concentration of SAMC for the induction of SW620 cell apoptosis was found to be 400 μM, which was confirmed through cell viability assays and apoptosis analysis. The current study indicated that SAMC inhibits cell proliferation and induces apoptosis of SW620 cells via the JNK and p38 pathways. The results from the current study demonstrated that SAMC must be further investigated as a novel preventive or therapeutic agent for the treatment of colorectal carcinoma, and potentially for use in other tumor types.
BibTeX
@inproceedings{zhang2014garlic,
  author = {Yan Zhang and H. Li and Zhihua Zhang and Honglei Bian and Lin Gui},
  title = {{Garlic-derived compound S-allylmercaptocysteine inhibits cell growth and induces apoptosis via the JNK and p38 pathways in human colorectal carcinoma cells}},
  booktitle = {Oncology},
  year = {2014},
  doi = {10.3892/ol.2014.2579},
}
Figure